LILY Phillips has revealed she is taking HIV protection drug PrEP ahead of her next sex challenge. But viewers have claimed ...

The US PrEP market is dominated by Truvada (plus generic versions of the drug in some markets), as well as Gilead's follow-up Descovy (emtricitabine and tenofovir alafenamide), a once-daily oral ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

alternative drug to ensure the continued profitability of Truvada. The drug also featured at the centre of legal proceedings between the US government and the company over patent ownership ...

Others are used to manage resulting symptoms like pain, depression, and muscle stiffness. There are several types of medications that can be used to treat MS, including chemotherapy drugs, ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Several drug classes are commonly used to treat MDD, including antidepressants, antipsychotics, anti-anxiety medications, and other types of mood-stabilizing drugs. This variety of classes can help ...

Tyler Van Buren, an analyst from TD Cowen, maintained the Buy rating on Gilead Sciences (GILD – Research Report). The associated price target ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...